Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be announcing earnings results tomorrow after the bell. Here’s what to expect.
LeMaitre beat analysts’ revenue expectations by 2.1% last quarter, reporting revenues of $54.82 million, up 15.6% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts’ organic revenue estimates and a solid beat of analysts’ EPS guidance for next quarter estimates.
Is LeMaitre a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting LeMaitre’s revenue to grow 14.7% year on year to $56.08 million, slowing from the 19.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.49 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. LeMaitre has missed Wall Street’s revenue estimates three times over the last two years.
Looking at LeMaitre’s peers in the healthcare equipment and supplies segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Intuitive Surgical delivered year-on-year revenue growth of 25.2%, beating analysts’ expectations by 6.5%, and Integra LifeSciences reported revenues up 11.5%, falling short of estimates by 0.7%. Intuitive Surgical traded down 4% following the results.
Read our full analysis of Intuitive Surgical’s results here and Integra LifeSciences’s results here.
Stocks, especially growth stocks where cash flows further in the future are more important to the story, had a good 2024. An economic soft landing (so far), the start of the Fed's rate cutting campaign, and the election of Donald Trump were positives for the market, and while some of the healthcare equipment and supplies stocks have shown solid performance, the group has generally underperformed, with share prices down 4.4% on average over the last month. LeMaitre is up 3.7% during the same time and is heading into earnings with an average analyst price target of $98.40 (compared to the current share price of $104).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.